Janus Kinase Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RIGL | F | Rigel Pharmaceuticals, Inc. | -8.19 | |
GLPG | F | Galapagos NV | -1.78 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 1.25 | |
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 0.22 | |
IBB | B | iShares Nasdaq Biotechnology Index Fund | 0.14 | |
IBBQ | B | Invesco Nasdaq Biotechnology ETF | 0.05 | |
IWC | C | iShares Microcap ETF | 0.04 |
Compare ETFs
Related Industries:
Biotechnology
- Janus Kinase
Janus kinase (JAK) is a family of intracellular, nonreceptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. They were initially named "just another kinase" 1 and 2 (since they were just two of a large number of discoveries in a PCR-based screen of kinases), but were ultimately published as "Janus kinase". The name is taken from the two-faced Roman god of beginnings, endings and duality, Janus, because the JAKs possess two near-identical phosphate-transferring domains. One domain exhibits the kinase activity, while the other negatively regulates the kinase activity of the first.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles